Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs industries have also been greatly affected.
In the past few years, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market experienced a growth of xx, the global market size of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs reached 1254.59 million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size in 2020 will be 1254.59 with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size will reach 2067.0 million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
XIFAXAN
Viberzi
Lotronex
Industry Segmentation
Hospitals Pharmacy
Retail Pharmacy
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Definition
Section 2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments
2.2 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
2.4 COVID-19 Impact on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry
Section 3 Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.1 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.1.1 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region
3.1.3 Bausch Health Interview Record
3.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Profile
3.1.5 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
3.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.2.1 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region
3.2.3 Interview Record
3.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview
3.2.5 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.3.1 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview
3.3.5 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
3.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.5 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
3.6 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
…
Section 4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.1.2 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.3.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.3.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.3.4 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.4.2 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.4.3 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.4.4 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.5.2 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.5.3 GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2015-2020
4.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Analysis
Section 5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level)
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type Price 2015-2020
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Analysis
Section 6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level)
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Analysis
Section 7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level)
7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Analysis
Section 8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast 2020-2025
8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Region Level)
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Product Type Level)
8.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Industry Level)
8.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Channel Level)
Section 9 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Product Type
9.1 XIFAXAN Product Introduction
9.2 Viberzi Product Introduction
9.3 Lotronex Product Introduction
Section 10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Industry
10.1 Hospitals Pharmacy Clients
10.2 Retail Pharmacy Clients
Section 11 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture from Bausch Health
Chart 2015-2020 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments (Units)
Chart 2015-2020 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments Share
Chart 2015-2020 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue Share
Chart Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution
Chart Bausch Health Interview Record (Partly)
Figure Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Chart Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Profile
Table Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Chart Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution
Chart Allergan Interview Record (Partly)
Figure Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Chart Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview
Table Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Chart Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution
Chart Sebela Pharmaceuticals Interview Record (Partly)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Chart Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview
Table Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
3.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction
…
Chart United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2015-2020
Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Market size 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type Price ($/Unit) 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Share 2015-2020
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Region Level) 2020-2025
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Industry Level) 2020-2025
Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Channel Level) 2020-2025
Chart XIFAXAN Product Figure
Chart XIFAXAN Product Advantage and Disadvantage Comparison
Chart Viberzi Product Figure
Chart Viberzi Product Advantage and Disadvantage Comparison
Chart Lotronex Product Figure
Chart Lotronex Product Advantage and Disadvantage Comparison
Chart Hospitals Pharmacy Clients
Chart Retail Pharmacy Clients
Research Methodology:
Irritable Bowel Syndrome with Diarrhea (IBS D) Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|